Abstract

We developed a quantitative and very sensitive method that combines molecular beacon (1) and locked nucleic acid (LNA) technologies (2) in a single sealed tube. We used the oncogenic somatic JAK2 V617F single-base sequence variant, observed in a broad range of Philadelphia chromosome-negative myeloproliferative diseases (MPDs) (3), to test this method of detection of somatic point variants. We used the molecular beacon to specifically detect the JAK2 V617F mutant allele and the LNA oligonucleotide to limit amplification of the wild-type JAK2 sequences (see Fig. 1 in the Data Supplement that accompanies the online version of this letter at http://www.clinchem.org/content/vol52/issue7). With this method, we detected very small quantities of mutant alleles in tubes containing the homozygous JAK2 V617F mutant cell line (HEL cell line) mixed with various amounts of wild-type cells and in clinical specimens containing small amounts of JAK2 V617F mutated cells. Primers and beacon probe were designed with the freeware MELT-CALC, Ver. 2.0 (http://www.meltcalc.de/). The melting temperature ( T m) of the molecular beacon stems was calculated by use of the Mfold algorithm (http://www.bioinfo.rpi.edu/applications/mfold/old/dna/form1.cgi), whereas the T m of the LNA was calculated via the Exiqon website (http://lna-tm.com). …

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.